Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2025 ,inter alia, to consider and approve To offer and issue of equity shares of the Company by way of a rights issue to eligible shareholders of the Company as on the record date (to be decided at a later date) for an amount not exceeding ? 36 crore in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other applicable laws (the \Rights Issue\).